コレステロールバイオシンセシスの阻害剤は,Staphylococcus aureusの毒性を阻害する
Chia-I Liu1, George Y Liu, Yongcheng Song
1Institute of Biological Chemistry, Academia Sinica, Nankang, Taipei 11529, Taiwan.
Science (New York, N.Y.)
|February 16, 2008
まとめ
研究者らは,Staphylococcus aureusをブロックすることで,
科学分野:
- 微生物学 微生物学とは
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
背景:
- Staphylococcus aureusは重大な感染を引き起こし,MRSAは大きな脅威となっています.
- S. aureusが産生する染色体であるスタフィロキサンチンは,宿主の防御に対する細菌の耐性を高めます.
- スタフィロキサンチンの酵素経路は,ヒトのコレステロール生物合成と類似しています.
研究 の 目的:
- S. aureus dehydrosqualene synthase (CrtM) の結晶構造を決定するために.
- S. aureus.に対する治療戦略としてスタフィロキサンチン生物合成を阻害する可能性を調査する.
主な方法:
- CrtMの結晶構造を1.58アングストームの解像度で決定した.
- CrtM.に対する活性について,9つのスクアレン合成酵素 (SQS) 阻害剤をスクリーニングした.
- CrtM.に結合する3つのSQS阻害剤の構造を決定した.
主要な成果:
- CrtMと人間のSQSの構造的な類似性が見つかりました.
- in vitroでスタフィロキサンチン生物合成を効果的に阻害するSQS阻害剤を特定しました.
- スタフィロキサンチン産生を阻害すると,宿主免疫クリアランスに対する細菌の感受性が増加することが実証されました. in vitro と in vivo.
結論:
- スタフィロキサンチン生物合成をターゲットにすることは,S. aureus感染症に対する有効な戦略です.
- ウイルス性因子に基づく治療は,抗生物質耐性細菌との闘いに有望なアプローチを提供します.
- CrtMに関する構造的洞察は,新しい抗スタフィロコッカ菌剤の開発を導くことができます.
さらに関連する動画
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
08:03A Tandem Liquid Chromatography–Mass Spectrometry-based Approach for Metabolite Analysis of Staphylococcus aureus
Published on: March 28, 2017
関連する概念動画
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...